-
,for, Item ID-
- #1224784
- LumiraDx Inc #L018180130384
Molecular Reagent LumiraDx™ SARS-CoV-2 RNA STAR Complete For Thermocycler 384 Tests
TEST, LUMIRADX SARS-COV-2 RNA STAR COMPLETE EUA (384/KT) D/S
Features
- The LumiraDX SARS-CoV-2 RNA STAR Complete is for Emergency Use Authorization (EUA) Only: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-molecular-diagnostic-tests-sars-cov-2#individual-molecular
- LumiraDx SARS-CoV-2 RNA STAR Complete is a rapid, non-isothermal nucleic acid amplification qSTAR (Selective Temperature Amplification Reaction) method intended for the qualitative detection of nucleic acid from SARS-CoV-2 in anterior nasal, mid-turbinate nasal, nasopharyngeal and oropharyngeal swab specimens collected dry or in transport media from individuals suspected of COVID-19 by their healthcare provider (HCP)
- This test is also authorized for use with anterior nasal swab specimens collected dry or in transport media from any individual, including individuals without symptoms or other reasons to suspect COVID-19 when collected by a HCP or self-collected under the supervision of a HCP
- More …
Product Details Email
Product Specifications
McKesson # | 1224784 |
---|---|
Manufacturer # | L018180130384 |
Brand | LumiraDx™ |
Manufacturer | LumiraDx Inc |
Country of Origin | Unknown |
Application | Molecular Reagent |
For Use With | For Thermocycler |
Number of Tests | 384 Tests |
Product Dating | McKesson Acceptable Dating: we will ship >= 90 days |
Sample Type | Anterior Nasal / Mid-turbinate Nasal / Nasopharyngeal / Oropharyngeal Swab Sample |
Specialty | Molecular |
Test Category | Respiratory |
Test Format | 384-Well Plate |
Test Method | Rapid Non-Isothermal Nucleic Acid Amplification qSTAR Method |
Test Name | SARS-CoV-2 RNA STAR Complete |
Test Type | Real-time PCR |
UNSPSC Code | 41116127 |
Features
- The LumiraDX SARS-CoV-2 RNA STAR Complete is for Emergency Use Authorization (EUA) Only: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-molecular-diagnostic-tests-sars-cov-2#individual-molecular
- LumiraDx SARS-CoV-2 RNA STAR Complete is a rapid, non-isothermal nucleic acid amplification qSTAR (Selective Temperature Amplification Reaction) method intended for the qualitative detection of nucleic acid from SARS-CoV-2 in anterior nasal, mid-turbinate nasal, nasopharyngeal and oropharyngeal swab specimens collected dry or in transport media from individuals suspected of COVID-19 by their healthcare provider (HCP)
- This test is also authorized for use with anterior nasal swab specimens collected dry or in transport media from any individual, including individuals without symptoms or other reasons to suspect COVID-19 when collected by a HCP or self-collected under the supervision of a HCP
- This test is also authorized for use with anterior nasal swab specimens that are collected using a collection kit that conforms to HealthPulse@home when used consistent with its authorization
- Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 USC. §263a that meet requirements to perform high complexity tests
- Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions; negative results must be combined with clinical observations, patient history, and epidemiological information
- Specimens included in pools with a positive or presumptive positive result must be tested individually prior to reporting a result
- Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status
- Laboratories within the United States and its territories are required to report all results to the appropriate public health authorities
- Materials provided: 500 µL positive control media, 1.5 mL negative control media, 2 mL Salt Mix, 1 mL extraction buffer, 240 µL internal control and primer mix, 2 X 2 mL Master Mix
- Options for PCR Instruments (not provided): Roche LightCycler 480 II (software version SW 1.5.1), Applied Biosystems 7500 Fast Dx (software version 1.4.1), Applied Biosystems QuantStudio 5 (software version 1.5.1), Applied Biosystems QuantStudio 7 Flex (software version 1.3), Applied Biosystems QuantStudio 7 Pro (software version 2.4.3), Bio-Rad CFX96 Touch System (software version 3.1), Agilent AriaMx (software version 1.71), Agilent Stratagene Mx3005P (software version 4.10) or the Analytik Jena qTOWER3 (software version 4.1) RT-PCR Instruments
More Information
Professionals Also Viewed
-
,for, Item ID-
- #1080512
- Providers like you icon 476
- Cepheid #XPRSTREPA-10
- Xpert® Xpress Strep A is a qualitative real-time PCR test providing ac …
- Xpert® Xpress Strep A provides medically actionable and timely informa …
- For In Vitro Diagnostic Use
-
,for, Item ID-
- #1045073
- Providers like you icon 231
- Cepheid #GXCT/NG-10
- 90 minute detection and differentiation of Chlamydia trachomatis (CT) …
-
,for, Item ID-
- #931480
- BD #441124
- Qualitative detection of Neisseria gonorrhoeae DNA in clinician-collec …
-
,for, Item ID-
- #1177911
- Providers like you icon 111
- Roche #09211101190
- cobas® SARS-CoV-2 & Influenza A/B nucleic acid test for use on the cob …
- Product ships from McKesson with minimum 30 days dating
- The cobas® SARS-CoV-2 & Influenza A/B Nucleic acid test for use on the …